Memorial Sloan Kettering Cancer Center

This study tested a new device that delivers targeted radiation to the skin for treating early-stage basal and squamous cell skin cancers. 36 people aged 60 and older with small, low-risk tumors received this treatment. The goal was to see how well it controls the cancer, its saf…

This study tested the safety and effectiveness of combining two targeted drugs, copanlisib and ibrutinib, in 18 adults with primary CNS lymphoma that had returned or not responded to prior therapy. The goal was to find the best dose and see how many patients' tumors shrank. This …

This study tested whether a smaller dose of radiation can still control high-risk neuroblastoma while causing fewer long-term side effects. 78 children with high-risk neuroblastoma received reduced-dose radiation to the main tumor site. Researchers tracked how well the cancer was…

This study tested whether giving the chemotherapy drug romidepsin after a stem cell transplant helps keep T-cell lymphoma from coming back. 47 patients who were already in remission received the drug as maintenance therapy. The goal was to see how many remained cancer-free two ye…

This early-phase study tested whether adding immune drugs (nivolumab alone or with ipilimumab) to standard chemotherapy is safe for people with advanced high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. 27 participants received the combination before and af…

This study tested whether adding the targeted drug panitumumab to a combination of liver-directed chemotherapy (hepatic arterial infusion) and standard IV chemo could help keep colorectal cancer from returning after liver metastases were surgically removed. 75 adults with a speci…

This study tested a drug called vemurafenib (Zelboraf) in 36 adults with hairy cell leukemia that had returned or not responded to standard treatments. The goal was to see how well the drug could clear leukemia cells from the blood and what side effects it might cause. Participan…

This study tested a new way to treat multiple myeloma by starting with only two drugs (bortezomib and dexamethasone) and adding a third drug (lenalidomide) only if the disease did not respond well. The goal was to see if this step-by-step approach could achieve the same good resu…

This study looked at two ways to help older patients (65+) with head and neck cancer manage side effects during radiation and chemotherapy. One approach involved a geriatric specialist working with the cancer team, and the other provided extra supportive care guidance. The goal w…

This study looked at 111 people who had surgery for early-stage cervical or vulvar cancer to find out how many later developed leg swelling (lymphedema). Researchers used a questionnaire to collect information, but no treatments or tests were given. The goal was to better underst…